Control of risk factors in peripheral vascular disease: Management of hypertension

Surgical Clinics of North America

Volumn 78, Issue 3, 1998, Pages 369-384

  Altemose, G T ^a   Wiener, D H ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CALCIUM ANTAGONIST; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ETACRYNIC ACID; FUROSEMIDE; GUANABENZ; GUANADREL; GUANETHIDINE; GUANFACINE; HYDRALAZINE; LABETALOL; METHYLDOPA; MINOXIDIL; PRAZOSIN; RESERPINE; SPIRONOLACTONE; TERAZOSIN; TRIAMTERENE; VERAPAMIL;

ALCOHOL CONSUMPTION; COST EFFECTIVENESS ANALYSIS; DRUG CONTRAINDICATION; HUMAN; HUMAN TISSUE; HYPERTENSION; PATHOPHYSIOLOGY; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVIEW; RISK FACTOR; SODIUM INTAKE;

EID: 0031775569     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70320-0     Document Type: Article

References (64)

1. B. Ablad J.A. Biorkman D. Gustaffson The role of sympathetic activity in atherogenesis: Effects of beta blockade Am Heart J 116 1988 322
2. I.J. Appel T.J. Moore E. Obarzanek A clinical trial of the effects of dietary patterns on blood pressure N Engl J Med 336 1997 1117
3. P.M.W. Bath D.G. Hassal A.M. Gladwin Nitric oxide and prostacyclin: Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro Arterioscl Thromb Vasc Biol 11 1991 254
4. H.R. Black Blood pressure control Am J Med 101 1996 53S
5. N.O. Borhani M. Mercuri P.A. Borhani Final outcome of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled study JAMA 276 1996 785
6. V.L. Burt P. Whelton E.J. Roccella Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988–1991 Hypertension 25 1995 305
7. A.V. Chobanian Can antihypertensive drugs reduce atherosclerosis and its clinical complications? Am J Hypertens 7 Suppl 1994 119
8. A.V. Chobanian P.I. Brecher C.C. Haudenschild Effects of hypertension and of antihypertensive therapy on atherosclerosis Hypertension 8 Suppl I 1986 I-15
9. R. Collins R. Peto S. MacMahon Blood pressure, stroke and coronary heart disease. II: Short-term reductions in blood pressure, overview of randomized drug trial in their epidemiological context Lancet 335 1990 827
10. J.M. Cruickshank Coronary flow reserve and the J curve relationship between diastolic blood pressure and myocardial infarction Br Med J 297 1988 1227
11. J.A. Cutler D. Follmann P. Elliot An overview of randomized trials of sodium reduction and blood pressure Hypertension 17 Suppl I 1991 I 27
12. B. Dahlof L.H. Lindholm L. Hansson Morbidity and mortality in the Swedish Trial in Old Persons with Hypertension Lancet 338 1991 1281
13. R.A. Davidson C.S. Wilcox Newer tests for the diagnosis of renovascular disease JAMA 268 1992 3353
14. E. Ferrannini G. Buzzigoli R. Bonadonna Insulin resistance in essential hypertension N Engl J Med 317 1987 350
15. E. Ferrannini A. Natali Essential hypertension, metabolic disorders and insulin resistance Am Heart J 121 4 Pt 2 1991 1274
16. J.M. Flack K.E. Ensrud S. Mascioli Racial and ethnic modifiers of the blood pressure response Hypertension 17 Suppl I 1991 I 115
17. A.E. Fletcher C.J. Bulpitt How far should blood pressure be lowered? N Engl J Med 326 1992 251
18. G.F. Fletcher S.N. Blair J. Blumenthal Benefits and recommendations for physical activity programs for all Americans Circulation 86 1992 340
19. C.D. Furberg N.O. Borhani R.P. Byington The Multicenter Isradipine/Diuretic Atherosclerosis Study Am J Hypertens 6 3 Pt 2 1993 24S
20. T. Gordon W.B. Kannel Predisposition to atherosclerosis in the head, heart, and legs. The Framingham Study JAMA 221 1972 661
21. G. Greenberg S.G. Thompson P.J. Brennan The relationship between smoking and the response to antihypertensive treatment in mild hypertensives in the Medical Research Council's trial of treatment Int J Epidemiol 16 1987 25
22. D.E. Grobbee Methodology of sodium sensitivity assessment: The example of age and sex Hypertension 17 Suppl I 1991 I-109
23. W.R. Hiatt S. Stoll A.S. Nies Effect of beta adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease Circulation 72 1985 1226
24. N.K. Hollenberg Medical therapy for renovascular hypertension: A review Am J Hypertens 1 1988 338S
25. Intersalt Cooperative Research Group Intersalt: An international study of electrolyte excretion and blood pressure; results for 24-hour urinary sodium and potassium excretion Br Med J 297 1988 319
26. Intersalt Cooperative Research Group Sodium, potassium, body mass, alcohol and blood pressure: The INTERSALT study J Hypertens 6 Suppl 4 1988 S5894
27. H. Itoh M. Mukoyama R.E. Pratt Multiple autocrine growth factors modulate vascular smooth muscle growth response to angiotensin II J Clin Invest 91 1993 2268
28. J.L. Juergens N.W. Barker E.A. Hines Arteriosclerosis obliterans: Review of 520 cases with special reference to pathogenic and prognostic factors Circulation 21 1960 188
29. S. Julius K. Jamerson A. Mejia The association of borderline hypertension with target organ changes and higher coronary risk JAMA 264 1990 354
30. W.B. Kannel Blood pressure as a cardiovascular risk factor: Prevention and treatment JAMA 275 1996 1571
31. W.B. Kannel Role of blood pressure in cardiovascular morbidity and mortality Prog Cardiovasc Dis 17 1974 5
32. W.B. Kannel Some lessons in cardiovascular epidemiology from Framingham Am J Cardiol 37 1976 269
33. N.M. Kaplan Primary hypertension Kaplan N.M. Clinical Hypertension ed 5 1990 Williams & Wilkins Baltimore 54
34. A.L. Klatsky G.D. Friedman A.B. Siegelaub Alcohol consumption and blood pressure. Kaiser Permanente multiphase health examination data N Engl J Med 296 1977 1194
35. D.M. Kramsch R.C. Sharma Limits of lipid lowering therapy: The benefits of amlodipine as an antiatherosclerotic agent J Hum Hypertens 9 Suppl I 1995 53
36. H.G. Langford B.R. David M.D. Blaufox Effect of drug and diet treatment of mild hypertension on diastolic blood pressure Hypertension 17 1991 210
37. H.G. Langford J. Stamler S. Wassertheil-Smoller All-cause mortality in the Hypertension Detection and Follow-up Program: Findings in the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality Prog Cardiovasc Dis 29 Suppl I 1986 29
38. M.R. Law C.D. Frost N.J. Wald By how much does dietary salt reduction lower blood pressure? I: Analysis of observational data among populations Br Med J 302 1991 811
39. M.R. Law C.D. Frost N.J. Wald By how much does dietary salt reduction lower blood pressure? III: Analysis of data from trials of salt reduction Br Med J 302 1991 819
40. A. Lehtonen Effect of beta blockers on blood lipid profile Am Heart J 109 5 Pt 2 1985 1192
41. P.R. Lichtlen P.G. Hugenholz W. Raffenbeul Retardation of angiographic progression of coronary artery disease by nifedipine Lancet 335 1990 1109
42. T.F. Lutscher F.C. Tanner M.R. Tschudi Endothelial dysfunction in coronary artery disease Annu Rev Med 44 1993 395
43. S.J. Mann T.G. Pickering Detection of renovascular hypertension. State of the art: 1992 Ann Intern Med 117 1992 845
44. J.E. Martin P.M. Dubbert W.C. Cushman Controlled trial of aerobic exercise in hypertension Circulation 81 1990 1560
45. D. McCarron Cardiovascular medicine subsection Scientific American Medicine, Section VII 1994 Scientific American New York 1
46. S. Moncada R.M.J. Palmer E.A. Higgs Nitric oxide physiology, pathophysiology and pharmacology Pharmacol Rev 43 1991 109
47. MRC Working Party Medical Research Council trial of treatment of hypertension in older adults: Principal results Br Med J 304 1992 405
48. A.C. Novick Management of renovascular disease, a surgical perspective Circulation 2 Suppl 1991 I-167
49. J.F. Potter D.T.G. Beevers The possible mechanisms of alcohol associated hypertension Ann Clin Res 16 Suppl 143 1984 97
50. D.H. Roberts Y. Tsao G.A. McLoughlin Placebo-controlled comparison of atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication Lancet 2 1987 650
51. W.C. Roberts The hypertensive diseases. Evidence that systemic hypertension is a greater risk factor to the development of other cardiovascular diseases than previously suspected Am J Med 59 1975 523
52. D.E. Schotte A.J. Stunkard The effects of weight reduction on blood pressure in 301 obese patients Arch Intern Med 150 1990 1701
53. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension JAMA 265 1991 3255
54. J.R. Sowres P.R. Standley J.L. Ram Insulin resistance, carbohydrate metabolism, and hypertension Am J Hypertens 4 7 pt 2 1991 466S
55. T.L. Svendsen R. Jeines K.H. Tonnesen The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with peripheral vascular disease Acta Med Scand 219 1986 161
56. The Fifth Report of the Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure (JNC V) Arch Intern Med 153 1993 154
57. D. Walters J. Lesperance M. Francetich A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis Circulation 82 1990 1940
58. M.A. Weber Hypertension as a risk factor syndrome: Therapeutic implications Am J Med 94 1993 24S
59. D.B. Weinstein The antiatherogenic potential of calcium antagonists J Cardiovasc Pharmacol 12 Suppl 6 1988 S29
60. G. Wiemer B.A. Scholkens R.H.A. Becker Ramiprilat enhances endothelial autocoid formation by inhibiting breakdown of endothelium-derived bradykinin Hypertension 23 1994 823
61. D.H. Wiener A.A. Bove Management of hypertension Kerstein M.D. White J.F. Alternatives to Open Vascular Surgery 1995 JB Lippincott Philadelphia 45
62. Working Group on Renovascular Hypertension Detection: Evaluation and treatment of renovascular hypertension: Final report Arch Intern Med 147 1987 820
63. World Hypertension League Alcohol and hypertension—implications for management J Hum Hypertens 5 1991 1854
64. World Hypertension League Physical exercise in the management of hypertension J Hypertens 9 1991 283